Videos de Experimentos Relacionados
¿Las unidades de tratamiento de apoplejía salvan vidas?
Lancet (London, England)
|October 16, 1993
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.
Cancers·2025
Same author
Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.
Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author
Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017.
Current oncology (Toronto, Ont.)·2018
Same author
Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012.
HIV medicine·2016
Same author
Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir.
Journal of viral hepatitis·2014
Same journal
Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.
Lancet (London, England)·2026
Same journal
Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.
Lancet (London, England)·2026
Same journal
Inherited retinal degenerations: clinical phenotypes and emerging therapies.
Lancet (London, England)·2026
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026